Clinical efficacy of addition of Agastya Haritaki avaleha [Classical Ayurvedic formulation] and Yoga to standard treatment care in the management of Bronchial Asthma in Children and Adolescents. A randomized controlled trial

Centre for Integrative Medicine and Research CIMR0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1. Diagnosed cases of Bronchial Asthma with follow up of > 6 weeks and at least 3 episodes of asthma symptoms during the previous year.
•2. Moderate stable asthma defined by FEV 1 more than 60 percent and less than 80 percent of that predicted by Polgar equation.
•3. Able to generate a peak inspiratory flow rate of 60 L per minute.
•4. Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency.
•5. Night symptoms twice a month but less than once a week.
•6. Parents or legal guardians willing to give written informed consent.
•7. Able and willing to follow all study related instructions

•1. Evidence of active concomitants pulmonary disease other than asthma e.g. Tuberculosis etc.
•2. Evidence of requirement of intubations for asthma, or had been hospitalized for asthma within one month before.
•3. More than 4 short courses of oral corticosteroids within the year preceding the screening visit, or any oral corticosteroids in the preceding 4 weeks.
•4. Concomitant severe decompensated systemic disease (cardiovascular, renal, hepatic, endocrine, haematological, neurological, immunological).

发起方

Centre for Integrative Medicine and Research CIMR